中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

从解剖学角度探讨原发性肝癌的转移途径

伍慧丽 郑素军 段钟平

引用本文:
Citation:

从解剖学角度探讨原发性肝癌的转移途径

DOI: 10.3969/j.issn.1001-5256.2017.10.035
详细信息
  • 中图分类号: R735.7

Route of metastasis of primary hepatic carcinoma from the perspective of anatomy

  • 摘要: 原发性肝癌(PHC)常通过多种途径或方式向肝内外转移,从而导致治疗的失败或治疗后复发,PHC患者的死因中90%是由于转移。总结了PHC转移的常见途径:包括血道途径(门静脉途径和肝静脉途径)、淋巴道途径、胆道途径以及其他途径(临近器官直接侵犯和种植性转移),分析了每种转移途径的基本特征、临床意义以及未来的研究方向,认为这些转移途径与解剖学均有着密不可分的联系。

     

  • [1]CHEN JG, CHEN WQ, ZHANG SW, et al.Incidence and mortality of liver cancer in China:an analysis on data from the National Registration System between 2003 and 2007[J].Chin J Epidemiol, 2012, 33 (6) :547-553. (in Chinese) 陈建国, 陈万青, 张思维, 等.中国2003-2007年肝癌发病率与死亡率分析[J].中华流行病学杂志, 2012, 33 (6) :547-553.
    [2]UCHINO K, TATEISHI R, SHIINA S, et al.Hepatocellular carcinoma with extrahepatic metastasis:clinical features and prognostic factors[J].Cancer, 2011, 117 (19) :4475-4483.
    [3] ZHANG SX, ZHANG YX.Regional anatomy[M].Beijing:People's Medical Publishing House, 2015. (in Chinese) 张绍祥, 张雅香.局部解剖学[M].北京:人民卫生出版社, 2015.
    [4]LIU Y, WANG YR, WANG L, et al.Circulating hepatocellular cells are a bad prognostic factor for HCC patients[J].Hepatogastroenterology, 2015, 62 (140) :802-806.
    [5]FAN JL, YANG YF, YUAN CH, et al.Circulating tumor cells for predicting the prognostic of patients with hepatocellular carcinoma:a meta analysis[J].Cell Physiol Biochem, 2015, 37 (2) :629-640.
    [6]FERRAZ VR, VITORINO-ARAUJO JL, SEMENTILLI L.Lesion in scalp and skull as the first manifestation of hepatocellular carcinoma[J].Case Rep Neurol Med, 2016, 2016:2897048.
    [7]HONG YM, YOON KT, CHO M, et al.Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma[J].Clin Mol Hepatol, 2016, 22 (2) :267-271.
    [8]CHAUHAN U, RAJESH S, KASANA V, et al.Spermatic cord and peritoneal metastases from unruptured hepatocellular carcinoma[J].J Clin Diagn Res, 2015, 9 (10) :4-5.
    [9]LU D, LYU WF.Research progress in blood of liver cancer[J].Chin J Interv Imaging Ther, 2007, 4 (3) :227-231. (in Chinese) 鲁东, 吕维富.肝癌血供研究进展[J].中国介入影像与治疗学, 2007, 4 (3) :227-231.
    [10]SHI H.Relativity study between liver pathology and blood supply[J].Chin Med Pharm, 2012, 2 (22) :123-124, 134. (in Chinese) 石菡.肝癌病理与肝癌血供的相关性研究[J].中国医药科学, 2012, 2 (22) :123-124, 134.
    [11]SUN HT, ZHAO WW, CHEN CM, et al.Value of contrast-enhanced ultrasound of the portal vein in observing blood supply in hepatocellular carcinoma[J].Chin J Ultrasonogr, 2015, 24 (6) :547-548. (in Chinese) 孙厚坦, 赵威武, 陈朝旻, 等.门静脉超声造影对肝细胞癌血供的观察[J].中华超声影像学杂志, 2015, 24 (6) :547-548.
    [12]BARR DC, HUSSAIN HK.Mr imaging in cirrhosis and hepatocellular carcinoma[J].Magn Reson Imaging Clin N Am, 2014, 22 (3) :315-335.
    [13]ZHU K, CHEN J, LAI L, et al.Hepatocellular carcinoma with portal vein tumor thrombus:treatment with transarterial chemoembolization combined with sorafenib-a retrospective controlled study[J].Radiology, 2014, 272 (1) :284-293.
    [14]FUKUMOTO T, KIDO M, TAKEBE A, et al.New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch[J].Surg today, 2017.[Epub ahead of print]
    [15]SCHULZE K, GASCH C, STAUFER K, et al.Presence of epcam-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma[J].Int J Cancer, 2013, 133 (9) :2165-2171.
    [16]XIA F, LAU WY, XU Y, et al.Does hepatic ischemia-reperfusion injury induced by hepatic pedicle clamping affect survival after partial hepatectomy for hepatocellular carcinoma?[J].World JSurg, 2013, 37 (1) :192-201.
    [17]SUN YF, XU Y, YANG XR, et al.Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J].Hepatology, 2013, 57 (4) :1458-1468.
    [18]MENG QH.“One disaster after another”or“a new lease of life”-liver cirrhosis complicated by liver cancer[J/CD].Electr J Metabol Nutrit Cancer, 2017, 4 (1) :54. (in Chinese) 孟庆华.“雪上加霜”还是“枯木逢春”---肝硬化并发肝癌[J/CD].肿瘤代谢与营养电子杂志, 2017, 4 (1) :54.
    [19]ZHANG X, JIANG HZ, ZHU LY, et al.Differential diagnosis of portal vein thrombus from cancer embolus by spiral CT enhancement scanning[J].Med Imaging, 2015, 25 (10) :1812-1814. (in Chinese) 张鑫, 姜浩之, 朱礼尧, 等.螺旋CT增强扫描对门静脉癌栓与门静脉血栓的鉴别诊断[J].医学影像学杂志, 2015, 25 (10) :1812-1814.
    [20]YANG WB, LU CY, YANG HY, et al.The value of MRI in identifying portal vein tumor thrombus and portal venous thrombosis in hepatocellular carcinoma patient[J].China Mod Doct, 2016, 54 (11) :92-95. (in Chinese) 杨伟斌, 卢陈英, 杨宏远, 等.MRI在原发性肝细胞癌门静脉癌栓与血栓鉴别中的应用价值[J].中国现代医生, 2016, 54 (11) :92-95.
    [21]REN J, ZENG J, LYU Y, et al.Contrast-enhanced ultrasonography, baseline ultrasound and spiral computed tomography in the characterization of portal vein thrombosis[J].Chin J Ultrasonography, 2011, 20 (11) :944-946. (in Chinese) 任杰, 曾婕, 吕艳, 等.超声造影、常规超声、增强ct鉴别诊断门静脉癌栓与血栓的比较[J].中华超声影像学杂志, 2011, 20 (11) :944-946.
    [22]LIANG CH.CT diagnosis of liver diseases[M].Beijing:People's Medical Publishing House, 2009. (in Chinese) 梁长虹.肝脏疾病CT诊断[M].北京:人民卫生出版社, 2009.
    [23]WANG J, LI QY, CHEN Y, et al.Preliminary clinical study on characterization of portal vein embolus using single energy of spectral CT[J].J Med Imaging, 2013, 23 (2) :230-232, 236. (in Chinese) 王吉, 李欠云, 陈盈, 等.能谱CT单能量区分门静脉栓子性质的初步临床研究[J].医学影像学杂志, 2013, 23 (2) :230-232, 236.
    [24]SHUQUN C, MENGCHAO W, HAN C, et al.Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein[J].Hepatogastroenterology, 2007, 54 (74) :499-502.
    [25]SHI J, LAI EC, LI N, et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus[J].J Hepatobiliary Pancreat Sci, 2011, 18 (1) :74-80.
    [26]WANG J, LI Q, SUN Y, et al.Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV[J].Surg Oncol, 2009, 18 (1) :25-30.
    [27]KIM JM, KWON CH, JOH JW, et al.Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection[J].Hepatogastroenterology, 2015, 62 (138) :399-404.
    [28]SHIMADA S, KAMIYAMA T, YOKOO H, et al.Clinicopathological characteristics of hepatocellular carcinoma with microscopic portal venous invasion and the role of anatomical liver resection in these cases[J].World J Surg, 2017, 41 (8) :2087-2094.
    [29]YOPP AC, MOKDAD A, ZHU H, et al.Infiltrative hepatocellular carcinoma:natural history and comparison with multifocal, nodular hepatocellular carcinoma[J].Ann Surg Oncol, 2015, 22 (Suppl3) :s1075-s1082.
    [30]YE LY, CHEN W, BAI XL, et al.Hypoxia-induced epithelialto-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis[J].Cancer Res, 2016, 76 (4) :818-830.
    [31]QU LS, LIU JX, ZHU J, et al.Risk factors for prognosis of hepatocellular carcinoma after curative resection in patients with low hepatitis b viral load[J].Ann Hepatol, 2017, 16 (3) :412-420.
    [32]YANG P, LI QJ, FENG Y, et al.TGF-β-miR-34a-CCL22signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma[J].Cancer cell, 2012, 22 (3) :291-303.
    [33]ZHOU L, RUI JA, WANG SB, et al.Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma[J].Hepatobiliary Pancreat Dis Int, 2013, 12 (1) :68-73.
    [34]SAKON M, OGAWA H, FUJITA M, et al.Hepatic resection for hepatocellular carcinoma based on tumor hemodynamics[J].Hepatol Res, 2013, 43 (2) :155-164.
    [35]DANG X, LI L, LI S, et al.Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma:Most patients without inferior vena cava obstruction[J].Int J Clin Exp Med, 2015, 8 (6) :9071-9078.
    [36]LEE WC, FU M, LIU WH.Isolated right ventricular infiltrating tumour:metastatic hepatocellular carcinoma[J].Int J Cardiovasc Imaging, 2015, 31 (7) :1347-1349.
    [37] MIAO D, SUN YH, ZHANG H, et al.Tumor thrombus in the right atrium and pulmonary embolism in one patient with primary liver cancer[J].Women's Health Res, 2015, 14:160. (in Chinese) 缪丹, 孙咏红, 张辉, 等.原发性肝癌右房瘤栓、肺栓塞1例[J].中外女性健康研究, 2015, 14:160.
    [38]LI AJ, ZHOU WP, LIN C, et al.Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus:a new classification for surgical guidance[J].Hepatobiliary Pancreat Dis Int, 2013, 12 (3) :263-269.
    [39]JI SP, LI Q.Research advances in mechanism of lymph node metastasis[J].Chin J Clin Oncol, 2009, 36 (18) :1076-1079. (in Chinese) 吉胜朴, 李强.肝癌淋巴结转移机制研究进展[J].中国肿瘤临床, 2009, 36 (18) :1076-1079.
    [40]HASEGAWA K, MAKUUCHI M, KOKUDO N, et al.Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma:report of a Japanese nationwide survey[J].Ann Surg, 2014, 259 (1) :166-170.
    [41]HUANG MD, YU R, ZHANG JH, et al.An analysis of clinicopathologic features and prognosis of hepatocellular carcinoma with abdominal lymph node metastasis[J].J Chin Oncol, 2010, 16 (10) :809-812. (in Chinese) 黄明德, 于仁, 张建淮, 等.肝癌腹腔淋巴结转移的相关因素及预后分析[J].肿瘤学杂志, 2010, 16 (10) :809-812.
    [42]WANG JD.Combined therapy of primary liver cancer with lymph node metastasis[J].Surg Res New Technol, 2013, 2 (3) :145-148. (in Chinese) 王健东.原发性肝癌淋巴结转移的治疗[J].外科研究与新技术, 2013, 2 (3) :145-148.
    [43]LYU SD, YANG GS, YANG N.Selection of therapeutic methods for lymph node metastasis of primary liver cancer[J].Chin J Gen Surg, 2013, 22 (4) :524-526. (in Chinese) 闾少冬, 杨广顺, 杨宁.原发性肝癌淋巴转移治疗方法的选择[J].中国普通外科杂志, 2013, 22 (4) :524-526.
    [44]ZHAO ZH, ZHAO G, CHANG LG, et al.Features and ultrasonic diagnosis of internal mammary lymph node metastasis of primary liver cancer[J].Chin J Clin Oncol, 2010, 37 (18) :1069-1070. (in Chinese) 赵志华, 赵刚, 常立功, 等.原发性肝癌内乳淋巴结转移特征及超声诊断[J].中国肿瘤临床, 2010, 37 (18) :1069-1070.
    [45]LIAO WS, HE YY, LI JF.Research advances in association between vascular endothelial growth factor and liver cancer metastasis[J].J Hepatobiliary Surg, 2016, 24 (1) :77-78. (in Chinese) 廖文胜, 何阳阳, 李江发.血管内皮生长因子与肝癌转移关系的研究进展[J].肝胆外科杂志, 2016, 24 (1) :77-78.
    [46]ZHANG XK, SHI XT.Mechanisms of lymphangiogenesis and lymphatic metastasis of hepatocellular carcinoma[J].J Int Oncol, 2008, 35 (8) :616-618. (in Chinese) 张西坤, 石学涛.肝细胞肝癌淋巴管生成及淋巴转移的机制[J].国际肿瘤学杂志, 2008, 35 (8) :616-618.
    [47]LEE DY, PARK JW, KIM TH, et al.Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma[J].Strahlenther Onkol, 2015, 191 (11) :835-844.
    [48]CHEN Y, GAO SG, CHEN JM, et al.Risk factors for the long-term efficacy, recurrence, and metastasis in small hepatocellular carcinomas[J].Cell Biochem Biophys, 2015, 72 (2) :627-631.
    [49]XIA F, WU L, LAU WY, et al.Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis[J].PLo S One, 2014, 9 (4) :e95889.
    [50]WANG RT, LI JB, ZHANG LQ, et al.Relationship between clinicopathologic characteristics and prognosis of patients with lymph node metastasis of primary liver cancer[J].Chin J Dig Surg, 2015, 14 (2) :127-132. (in Chinese) 王瑞涛, 李建波, 张灵强, 等.原发性肝癌淋巴结转移临床病理特点与预后的关系[J].中华消化外科杂志, 2015, 14 (2) :127-132.
    [51] LIU JS.Analysisi of the relavant factors and prognosis of lymph node metastasis in hepatocellular carcinoma[D].Shenyang:China Medical University, 2015. (in Chinese) 刘佳松.肝细胞癌淋巴结转移的相关因素及预后分析[D].沈阳:中国医科大学, 2015.
    [52]LEE CW, KUO WL, YU MC, et al.The expression of cytokeratin19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection[J].World J Surg Oncol, 2013, 11 (1) :136.
    [53]XIANG ZL, ZENG ZC, TANG ZY, et al.Expression of cytokeratin19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma[J].Mol Biol Rep, 2011, 38 (5) :3531-3539.
    [54]ALBRECHT I, CHRISTOFORI G.Molecular mechanisms of lymphangiogenesis in development and cancer[J].Int J Dev Biol, 2011, 55 (4-5) :483-494.
    [55]LI L, SHI XT.Relationship between SDF-1/CXCR4 axis and lymphatic metastasis of HCC[J].Chin J Cancer Prev Treat, 2011, 18 (9) :737-740. (in Chinese) 李磊, 石学涛.SDF-1/CXCR4与肝细胞肝癌淋巴结转移的关系[J].中华肿瘤防治杂志, 2011, 18 (9) :737-740.
    [56]ZHANG L, XIANG ZL, ZENG ZC, et al.A microrna-based prediction model for lymph node metastasis in hepatocellular carcinoma[J].Oncotarget, 2016, 7 (3) :3587-3598.
    [57]WANG K, ZHU B, YANG SJ, et al.Research advances in diagnosis and treatment of hepatocellular carcinoma complicated by bile duct tumor thrombus[J].Chin J Gerontol, 2013, 33 (9) :2222-2225. (in Chinese) 王坤, 朱冰, 杨尚九, 等.肝细胞癌合并胆管癌栓诊断及治疗进展[J].中国老年学杂志, 2013, 33 (9) :2222-2225.
    [58]SU KL, WU YL, LI Y, et al.Correlation between clinicopathological characteristics and prognosis of hepatocellular carcinoma with bile duct thrombi[J].Chin J Hepatobiliary Surg, 2009, 15 (5) :371-373. (in Chinese) 苏昆仑, 吴育连, 李晔, 等.肝癌伴胆管癌栓的临床病理及预后分析[J].中华肝胆外科杂志, 2009, 15 (5) :371-373.
    [59]CUI H, GAO QQ, HUANG CS, et al.Diagnosis experience of liver cancinoma complicated with bile duct embolus[J].Chin Med Herald, 2006, 3 (26) :29-31. (in Chinese) 崔宏, 高琴琴, 黄长山, 等.肝癌合并胆道癌栓的诊断探讨[J].中国医药导报, 2006, 3 (26) :29-31.
    [60]ZHANG WW, DU JX, FAN YG.Pathological features of bile duct tumor thrombus and their influence on surgical outcome[J].Chin JMod Drug Appl, 2015, 9 (9) :78-79. (in Chinese) 张温温, 杜敬晓, 范永刚.胆管癌栓的病理学特点对手术预后的影响[J].中国现代药物应用, 2015, 9 (9) :78-79.
    [61]PANG YB, ZHONG JH, LUO XL, et al.Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi[J].Tumour Biol, 2016, 37 (5) :5879-5884.
    [62]IKENAGA N, CHIJIIWA K, OTANI K, et al.Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion[J].J Gastrointest Surg, 2009, 13 (3) :492-497.
    [63]HUANG RG, LI YM, SUN HF, et al.CT and MRI diagnosis of hepatocellular carcinoma with bile duct tumor thrombus[J].Chin Foreign Med Treat, 2014, 35:38-40. (in Chinese) 黄睿刚, 李毅敏, 孙海峰, 等.肝细胞癌并胆管癌栓的CT及MRI诊断[J].中外医疗, 2014, 35:38-40.
    [64]QIU ZQ.Significance and biological function of AQP5, CCL20 and NDRG2 in hepatocellular carcinoma with bile duct tumor thrombi[D].Shanghai:The Second Military Medical University, 2012. (in Chinese) 邱智泉.AQP5、CCL20及NDRG2在原发性肝细胞癌伴胆管癌栓中的表达意义及功能研究[D].上海:第二军医大学, 2012.
    [65]GUI WB, XIAO KY, LIN XJ, et al.Diagnosis analysis on 53 cases of hepatocellular carconoma with bile duct tumor thrombus[J].Hepatobiliary Surg, 2011, 19 (6) :435-436. (in Chinese) 桂文波, 肖开银, 林新居, 等.肝细胞癌合并胆管癌栓53例临床诊断分析[J].肝胆外科杂志, 2011, 19 (6) :435-436.
    [66]YAO XP, ZHOU WP, LI AJ, et al.Diagnosis and treatment of primary liver cancer with tumor thrombus in the bile duct[J].J Surg Concepts Pract, 2000, 5 (4) :238-240. (in Chinese) 姚晓平, 周伟平, 李爱军, 等.原发性肝癌伴胆管癌栓的诊断及治疗[J].外科理论与实践, 2000, 5 (4) :238-240.
    [67]SATOH S, IKAI I, HONDA G, et al.Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi[J].Surgery, 2000, 128 (5) :779-783.
    [68]UEDA M, TAKEUCHI T, TAKAYASU T, et al.Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi[J].Hepatogastroenterology, 1994, 41 (4) :349-354.
    [69]YANG DH.Metastasis and relapse of hepatocellular carcinoma[J].Chin J Hepatol, 2004, 12 (8) :491-492. (in Chinese) 杨冬华.肝癌的转移与复发[J].中华肝脏病杂志, 2004, 12 (8) :491-492.
    [70]DUAN JC, YANG JH, YUE HY.Diagnosis and treatment of gastric metastasis of primary liver cancer:a report of two cases and literature review[J].J Hepatobiliary Surg, 2013, 21 (5) :399-400. (in Chinese) 段纪成, 杨家和, 岳海燕.原发性肝癌胃转移的诊断与治疗 (附2例报道与文献复习) [J].肝胆外科杂志, 2013, 21 (5) :399-400.
    [71]HUANG F, ZHOU D, YING MG.Risk factors for intraperitoneal seeding related to liver resection for primary liver cancer postoperatively[J].Clin Med J China, 2011, 18 (6) :800-802. (in Chinese) 黄峰, 周东, 应敏刚.原发性肝癌术后腹腔种植转移危险因素分析[J].中国临床医学, 2011, 18 (6) :800-802.
    [72]WANG ZJ, ZHANG WW, SU YX.Ultrasound features of needle tract seeding after ultrasound intervention for primary liver cancer[J].Chin J Diffic Complic Cases, 2010, 9 (6) :445-446. (in Chinese) 王志杰, 张伟伟, 苏玉祥.原发性肝癌超声介入术后致针道种植的超声影像学观察[J].疑难病杂志, 2010, 9 (6) :445-446.
    [73]WU XY, ZHOU JX, ZHOU T, et al.Diagnosis and treatment of neoplastic needle tract seeding following radiofrequency ablation of primary hepatic carcinoma[J].Hepatobiliary Surg, 2011, 19 (6) :420-422. (in Chinese) 吴星宇, 周建新, 周铁, 等.原发性肝癌冷循环射频治疗术后针道种植转移的诊断与治疗[J].肝胆外科杂志, 2011, 19 (6) :420-422.
    [74]CHEN MH, GOLDBERG SN.radiofrequency ablation of liver tumor[M].Beijing:People's Medical Publishing House, 2009. (in Chinese) 陈敏华, GOLDBERG SN.肝癌射频消融---基础与临床[M].北京:人民卫生出版社, 2009.
    [75]WANG YM, WANG N, XU Y, et al.Severe complications after microwave ablation in 7403 cases with liver cancer[J].Chin JHepatobiliary Surg, 2016, 22 (10) :655-660. (in Chinese) 王延明, 王能, 许赟, 等.微波消融治疗7403例肝癌的严重并发症[J].中华肝胆外科杂志, 2016, 22 (10) :655-660.
  • 加载中
计量
  • 文章访问数:  2127
  • HTML全文浏览量:  59
  • PDF下载量:  410
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-03-21
  • 出版日期:  2017-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回